Edgewise Therapeutics, Inc. (EWTX) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts EWTX Hot Sheet
Join SI Premium – FREE
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q2 EPS of ($0.34), $0.08 better than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- loanDepot receives NYSE non-compliance notice over stock price
- Lazard Global Total Return fund declares $0.1534 monthly distribution
- Nuvectis Pharma (NVCT) files $200M mixed shelf
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
